Comparison of normal saline solution with low-chloride solutions in renal transplants: a meta-analysis

Background: Normal saline solution (NSS) has been the fluid of choice for renal transplant patients, but it can lead to hyperchloremic acidosis and hyperkalemia. This study was performed to compare the safety profile of low-chloride solutions with that of NSS in renal transplant patients. Methods: W...

Full description

Saved in:
Bibliographic Details
Published inKidney research and clinical practice Vol. 40; no. 3; pp. 484 - 495
Main Authors Abdullah Jahangir, Syeda Sahra, Muhammad Rafay Khan Niazi, Fasih Sami Siddiqui, Muhammad Yasir Anwar, Ahmad Jahangir, Elie J. El-charabaty
Format Journal Article
LanguageKorean
Published 대한신장학회 30.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Normal saline solution (NSS) has been the fluid of choice for renal transplant patients, but it can lead to hyperchloremic acidosis and hyperkalemia. This study was performed to compare the safety profile of low-chloride solutions with that of NSS in renal transplant patients. Methods: We conducted a systemic review search on PubMed, Embase, and the Central Cochrane Registry. Randomized clinical tri-als (RCTs) and matched cohort studies involving NSS as the control arm and low-chloride solutions as an intervention arm were cho-sen. The standardized mean difference for continuous variables, the odds ratio (OR) for discrete variables, and a 95% confidence in-terval (CI) for effect sizes were used. A p-value of <0.05 was considered statistically significant. Analysis was performed using a ran-dom-effects model irrespective of heterogeneity, which was evaluated using I 2 statistics. Results: Nine RCTs and one cohort study with a total of 726 patients were included. After transplantation, serum potassium was sig-nificantly lower in the low-chloride group (standardized mean difference compared to NSS group, -0.38 mEq/L; 95% CI, -0.66 to -0.11; p = 0.007). Similarly, postoperative chloride was lower in the low-chloride group (-2.41 mEq/L [-3.34 to -1.48], p < 0.001). No statistically significance was observed in delayed graft function (OR, 0.98 [0.56-1.69], p = 0.93), day 3 creatinine (-0.14 mg/dL [-0.46 to 0.18], p = 0.38), or day 7 urine output (-0.08 L [-0.29 to 0.12], p = 0.43). onclusion: Use of NSS during renal transplant leads to increased incidence of hyperchloremic acidosis with subsequent hyperkale-mia, but clinical significance in the form of delayed graft function or postoperative creatinine remains comparable to that of low-chlo-ride solutions.
Bibliography:The Korean Society of Nephrology
ISSN:2211-9132